Skip to main content
. Author manuscript; available in PMC: 2008 Aug 1.
Published in final edited form as: Drug Discov Today Dis Mech. 2007;4(4):231–236. doi: 10.1016/j.ddmec.2007.11.003

Table 1. Therapeutic targets in the innate immune response to MTb, and their effect on adaptive immune outcomes.

# Therapeutic Targets Approach Expected innate response Possible adaptive response References
1 TLR 2
(+1 or 6)
Agonist Strong IL-10
Weak IL 12p70
Th2 31,32
2 TLR 4 Agonist Strong IL-12p70
IFN α
Th1 31, 32, 45
3 TLR 9 Agonist Strong IFN α
Strong IL-12p70
Th1 31, 32, 33
4 NOD2 Agonist IL-23 Th17 35
5 DC-SIGN Agonist IL-10 Th2/Th0 34
6 Dectin-1 Agonist IL-12p40 ? Th1 13, 14